GRUSF
Price
$0.46
Change
-$0.02 (-4.17%)
Updated
Dec 26 closing price
Capitalization
118.53M
Intraday BUY SELL Signals
TCNNF
Price
$8.10
Change
+$0.26 (+3.32%)
Updated
Dec 24 closing price
Capitalization
1.54B
61 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

GRUSF vs TCNNF

Header iconGRUSF vs TCNNF Comparison
Open Charts GRUSF vs TCNNFBanner chart's image
Grown Rogue International
Price$0.46
Change-$0.02 (-4.17%)
Volume$41.71K
Capitalization118.53M
Trulieve Cannabis
Price$8.10
Change+$0.26 (+3.32%)
Volume$185.84K
Capitalization1.54B
GRUSF vs TCNNF Comparison Chart in %
GRUSF
Daily Signal:
Gain/Loss:
TCNNF
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
GRUSF vs. TCNNF commentary
Dec 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GRUSF is a StrongBuy and TCNNF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Dec 27, 2025
Stock price -- (GRUSF: $0.48 vs. TCNNF: $8.10)
Brand notoriety: GRUSF and TCNNF are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: GRUSF: 309% vs. TCNNF: 19%
Market capitalization -- GRUSF: $118.53M vs. TCNNF: $1.54B
GRUSF [@Pharmaceuticals: Generic] is valued at $118.53M. TCNNF’s [@Pharmaceuticals: Generic] market capitalization is $1.54B. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $63.66B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $4.46B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GRUSF’s FA Score shows that 1 FA rating(s) are green whileTCNNF’s FA Score has 1 green FA rating(s).

  • GRUSF’s FA Score: 1 green, 4 red.
  • TCNNF’s FA Score: 1 green, 4 red.
According to our system of comparison, GRUSF is a better buy in the long-term than TCNNF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GRUSF’s TA Score shows that 6 TA indicator(s) are bullish while TCNNF’s TA Score has 6 bullish TA indicator(s).

  • GRUSF’s TA Score: 6 bullish, 4 bearish.
  • TCNNF’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, both GRUSF and TCNNF are a good buy in the short-term.

Price Growth

GRUSF (@Pharmaceuticals: Generic) experienced а +12.36% price change this week, while TCNNF (@Pharmaceuticals: Generic) price change was -27.18% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +5.98%. For the same industry, the average monthly price growth was +12.50%, and the average quarterly price growth was +30.15%.

Reported Earning Dates

TCNNF is expected to report earnings on Feb 26, 2026.

Industries' Descriptions

@Pharmaceuticals: Generic (+5.98% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TCNNF($1.54B) has a higher market cap than GRUSF($119M). TCNNF YTD gains are higher at: 56.265 vs. GRUSF (-30.181). TCNNF has higher annual earnings (EBITDA): 322M vs. GRUSF (12.3M). TCNNF has more cash in the bank: 449M vs. GRUSF (13.1M). GRUSF has less debt than TCNNF: GRUSF (17.4M) vs TCNNF (813M). TCNNF has higher revenues than GRUSF: TCNNF (1.19B) vs GRUSF (22.2M).
GRUSFTCNNFGRUSF / TCNNF
Capitalization119M1.54B8%
EBITDA12.3M322M4%
Gain YTD-30.18156.265-54%
P/E Ratio15.23N/A-
Revenue22.2M1.19B2%
Total Cash13.1M449M3%
Total Debt17.4M813M2%
FUNDAMENTALS RATINGS
GRUSF vs TCNNF: Fundamental Ratings
GRUSF
TCNNF
OUTLOOK RATING
1..100
2550
VALUATION
overvalued / fair valued / undervalued
1..100
60
Fair valued
81
Overvalued
PROFIT vs RISK RATING
1..100
57100
SMR RATING
1..100
3294
PRICE GROWTH RATING
1..100
3936
P/E GROWTH RATING
1..100
8915
SEASONALITY SCORE
1..100
8534

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

GRUSF's Valuation (60) in the null industry is in the same range as TCNNF (81). This means that GRUSF’s stock grew similarly to TCNNF’s over the last 12 months.

GRUSF's Profit vs Risk Rating (57) in the null industry is somewhat better than the same rating for TCNNF (100). This means that GRUSF’s stock grew somewhat faster than TCNNF’s over the last 12 months.

GRUSF's SMR Rating (32) in the null industry is somewhat better than the same rating for TCNNF (94). This means that GRUSF’s stock grew somewhat faster than TCNNF’s over the last 12 months.

TCNNF's Price Growth Rating (36) in the null industry is in the same range as GRUSF (39). This means that TCNNF’s stock grew similarly to GRUSF’s over the last 12 months.

TCNNF's P/E Growth Rating (15) in the null industry is significantly better than the same rating for GRUSF (89). This means that TCNNF’s stock grew significantly faster than GRUSF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
GRUSFTCNNF
RSI
ODDS (%)
Bearish Trend 1 day ago
75%
Bearish Trend 3 days ago
81%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 3 days ago
90%
Momentum
ODDS (%)
Bullish Trend 1 day ago
86%
Bullish Trend 3 days ago
78%
MACD
ODDS (%)
Bullish Trend 1 day ago
74%
Bullish Trend 3 days ago
82%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
74%
Bearish Trend 3 days ago
87%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
77%
Bullish Trend 3 days ago
76%
Advances
ODDS (%)
Bullish Trend 5 days ago
76%
Bullish Trend 3 days ago
76%
Declines
ODDS (%)
Bearish Trend 9 days ago
87%
Bearish Trend 5 days ago
87%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
79%
Bearish Trend 3 days ago
90%
Aroon
ODDS (%)
Bullish Trend 1 day ago
75%
Bullish Trend 3 days ago
80%
View a ticker or compare two or three
Interact to see
Advertisement
GRUSF
Daily Signal:
Gain/Loss:
TCNNF
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
IOVVX32.690.15
+0.46%
Invesco Comstock Select R5
FLMVX32.290.08
+0.25%
JPMorgan Mid Cap Value L
PGEMX26.590.06
+0.23%
George Putnam Balanced M
IRFAX9.070.01
+0.11%
Cohen & Steers International Realty A
CGCYX46.49-0.05
-0.11%
Columbia Greater China Inst3

GRUSF and

Correlation & Price change

A.I.dvisor indicates that over the last year, GRUSF has been loosely correlated with GLASF. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if GRUSF jumps, then GLASF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GRUSF
1D Price
Change %
GRUSF100%
-4.77%
GLASF - GRUSF
34%
Loosely correlated
+3.41%
TSNDF - GRUSF
33%
Poorly correlated
-7.34%
TCNNF - GRUSF
29%
Poorly correlated
-2.59%
CURLF - GRUSF
28%
Poorly correlated
+4.06%
CRLBF - GRUSF
28%
Poorly correlated
-2.34%
More

TCNNF and

Correlation & Price change

A.I.dvisor indicates that over the last year, TCNNF has been closely correlated with GTBIF. These tickers have moved in lockstep 83% of the time. This A.I.-generated data suggests there is a high statistical probability that if TCNNF jumps, then GTBIF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TCNNF
1D Price
Change %
TCNNF100%
+3.32%
GTBIF - TCNNF
83%
Closely correlated
+5.03%
CURLF - TCNNF
80%
Closely correlated
-2.20%
TSNDF - TCNNF
76%
Closely correlated
+4.46%
CRLBF - TCNNF
75%
Closely correlated
+2.40%
JUSHF - TCNNF
73%
Closely correlated
-3.80%
More